News & Articles

The license from ERS expands ZeClinics CRISPR IP portfolio and increases the validity and potency of zebrafish models for the drug discovery process

Funding of $231.8 million U.S. awarded to Ellume COVID-19 Home Test that integrates AnteoBind™ for superior sensitivity

The research brings a deeper understanding about how fructose could be linked to diabetes and obesity

International experts are joining forces to combat vaccine hesitancy by tackling its root cause

The Genedrive 96 SARS-CoV-2 kit is a simple, one-step RT-PCR test to detect SARS-CoV-2 RNA

Companion diagnostic can help guide treatment decisions in cases of NSCLC

Neuroscientists can now screen over 3,000 neurons from a NeuroHTS microplate in under 30 minutes with the ImageXpress Pico Automated Cell Imaging System

Emergency Use Listing granted to AstraZeneca and Serum Institute of India enabling global access to the vaccine

Focusing on innate immunity opens way for precision medicine approaches to AD

Company expands portfolio of SARS-CoV-2 testing solutions with rapid antigen test benchmarked against gold standard RT-PCR

Eight-marker panel, including new long mononucleotide repeat (LMR) markers, enables broader view of mismatch repair deficiency

Watch our curated collection of The Scientists' Channel interviews from some of the experts joining us at this year's summit

Discover the latest technologies and techniques to aid research into the biology, detection, and prevention of SARS-CoV-2 infection

The SARS-CoV-2 Rapid Antigen Test Nasal uses a nasal swab to quickly and conveniently collect specimens from people suspected of having an active infection

The testing capacity provided by the Fluidigm system aims to help the university limit the spread of the virus

New partnership broadens access to oncology treatments across Latin America, Asia, Africa and the Western Pacific

RNA controls can help avoid false negative results

Partnership aims to accelerate CE marking of Avacta’s SARS-CoV-2 rapid antigen test and support COVID-19 testing

The test could be used to assess antibody response against the native spike protein of SARS-CoV-2 following COVID-19 vaccination

Arvind Kothandaraman discusses the importance of detecting new SARS-CoV-2 variants and future trends in COVID-19 diagnostics